Systemic Drug DeliveryDiabetes Market Opportunity

Type 1 and Type 2 diabetic patients

154 million

• Non-invasive delivery

• Increase compliance

• Improve glucose control

• Improve outcomes

Target Market

Worldwide Patients

Aerodose insulin inhaler

Previous slide

Next slide

Back to first slide

View graphic version